These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34338845)

  • 1. Effective systemic treatment of advanced periocular basal cell carcinoma with sonidegib.
    Rokohl AC; Heindl LM
    Graefes Arch Clin Exp Ophthalmol; 2021 Dec; 259(12):3821-3822. PubMed ID: 34338845
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial.
    Migden MR; Guminski A; Gutzmer R; Dirix L; Lewis KD; Combemale P; Herd RM; Kudchadkar R; Trefzer U; Gogov S; Pallaud C; Yi T; Mone M; Kaatz M; Loquai C; Stratigos AJ; Schulze HJ; Plummer R; Chang AL; Cornélis F; Lear JT; Sellami D; Dummer R
    Lancet Oncol; 2015 Jun; 16(6):716-28. PubMed ID: 25981810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced basal cell carcinoma with sonidegib: perspective from the 30-month update of the BOLT trial.
    Chen L; Aria AB; Silapunt S; Lee HH; Migden MR
    Future Oncol; 2018 Mar; 14(6):515-525. PubMed ID: 29119833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes With LDE225 Treatment (BOLT) trial at 42 months.
    Dummer R; Lear JT; Guminski A; Leow LJ; Squittieri N; Migden M
    J Am Acad Dermatol; 2021 Apr; 84(4):1162-1164. PubMed ID: 33358380
    [No Abstract]   [Full Text] [Related]  

  • 5. The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma.
    Dummer R; Guminski A; Gutzmer R; Dirix L; Lewis KD; Combemale P; Herd RM; Kaatz M; Loquai C; Stratigos AJ; Schulze HJ; Plummer R; Gogov S; Pallaud C; Yi T; Mone M; Chang AL; Cornélis F; Kudchadkar R; Trefzer U; Lear JT; Sellami D; Migden MR
    J Am Acad Dermatol; 2016 Jul; 75(1):113-125.e5. PubMed ID: 27067394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sonidegib (Odomzo) for basal cell carcinoma.
    Med Lett Drugs Ther; 2016 Feb; 58(1489):31-2. PubMed ID: 26938701
    [No Abstract]   [Full Text] [Related]  

  • 7. Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update.
    Chen L; Silapunt S; Migden MR
    Future Oncol; 2016 Sep; 12(18):2095-105. PubMed ID: 27189494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonidegib efficacy and tolerability in advanced basal cell carcinoma: A single-center real-life experience.
    Villani A; Fabbrocini G; Costa C; Scalvenzi M
    J Am Acad Dermatol; 2022 Apr; 86(4):e175. PubMed ID: 34838876
    [No Abstract]   [Full Text] [Related]  

  • 9. Sonidegib with and Without Adjunctive Treatment for Locally Advanced Basal Cell Carcinomas.
    Villani A; Fabbrocini G; Costa C; Potestio L; Scalvenzi M
    Oncologist; 2022 Jun; 27(6):e533. PubMed ID: 35436344
    [No Abstract]   [Full Text] [Related]  

  • 10. Effective management of infiltrative locally advanced basal cell carcinoma of the tibia with sonidegib.
    Venturi F; Lambertini M; Melotti B; De Paolis M; Dika E
    Int J Dermatol; 2024 May; 63(5):685-687. PubMed ID: 38351632
    [No Abstract]   [Full Text] [Related]  

  • 11. Sonidegib (Odomzo°) and extensive basal cell carcinoma.
    Prescrire Int; 2017 Jan; 26(178):14-15. PubMed ID: 30730637
    [No Abstract]   [Full Text] [Related]  

  • 12. Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic.
    Villani A; Fabbrocini G; Costa C; Scalvenzi M
    Dermatol Ther; 2020 Nov; 33(6):e14200. PubMed ID: 32870541
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-related adverse effects of vismodegib and sonidegib for locally advanced or metastatic basal cell carcinoma.
    Gibson M; Murrell DF
    Australas J Dermatol; 2020 May; 61(2):176-177. PubMed ID: 31747714
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to "Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT) trial at 42 months".
    Villani A; Fabbrocini G; Costa C; Scalvenzi M
    J Am Acad Dermatol; 2021 Jun; 84(6):e299-e300. PubMed ID: 33677004
    [No Abstract]   [Full Text] [Related]  

  • 15. Odomzo
    Gupta AK; Mays RR; Abramovits W; Vincent KD
    Skinmed; 2018; 16(1):35-38. PubMed ID: 29551110
    [No Abstract]   [Full Text] [Related]  

  • 16. Anal and rectal locally advanced basal cell carcinoma treated with sonidegib.
    Conforti C; Toffoli L; Degrassi F; di Meo N; Zalaudek I
    Dermatol Ther; 2022 Feb; 35(2):e15242. PubMed ID: 34854197
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of advanced basal cell carcinoma: Real-life data with sonidegib.
    Moscarella E; Brancaccio G; Briatico G; Ronchi A; Verolino P; Argenziano G; Alfano R
    Dermatol Ther; 2021 May; 34(3):e14948. PubMed ID: 33728757
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of locally advanced basal cell carcinoma treated with sonidegib: The experience of an Italian reference hospital.
    Conforti C; Giuffrida R; Di Meo N; Zalaudek I
    Dermatol Ther; 2020 Nov; 33(6):e14511. PubMed ID: 33166006
    [No Abstract]   [Full Text] [Related]  

  • 19. Dermatoscopy and locally advanced or multiple basal cell carcinomas: a non-invasive tool to evaluate sonidegib effectiveness.
    Conforti C; Toffoli L; Agozzino M; Di Meo N; Zelin E; Zalaudek I
    Dermatol Online J; 2021 Sep; 27(9):. PubMed ID: 34755992
    [No Abstract]   [Full Text] [Related]  

  • 20. Locally advanced basosquamous carcinoma: Our experience with sonidegib.
    Toffoli L; Agozzino M; di Meo N; Zalaudek I; Conforti C
    Dermatol Ther; 2022 Jun; 35(6):e15436. PubMed ID: 35278014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.